Effectiveness and tolerability of direct-acting antivirals for chronic hepatitis C patients in a Southern state of Brazil
Open Access
- 9 May 2018
- journal article
- research article
- Published by Elsevier BV in The Brazilian Journal of Infectious Diseases
- Vol. 22 (3), 186-192
- https://doi.org/10.1016/j.bjid.2018.04.003
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosisJournal of Hepatology, 2016
- EASL Recommendations on Treatment of Hepatitis C 2015Journal of Hepatology, 2015
- Hepatitis C virus infection treatment: An era of game changer direct acting antivirals and novel treatment strategiesCritical Reviews in Microbiology, 2014
- Observational studies: why are they so important?Sao Paulo Medical Journal, 2014
- Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis CHepatology, 2012
- Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis CNature Reviews Gastroenterology & Hepatology, 2011
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infectionJournal of Hepatology, 2011
- Evolving epidemiology of hepatitis C virusClinical Microbiology & Infection, 2011
- The global burden of hepatitis CLiver International, 2009
- Importance of Observational Studies in Clinical PracticeClinical Therapeutics, 2007